Organoid models have revolutionized drug screening, disease research, and precision medicine with their ability to mimic in vivo organs in a biomimetic microenvironment. Combining organoids with microfluidics in organoid-on-a-chip systems offers precise control over biochemical factors and fluid conditions, enhancing their relevance to clinical applications. While traditional 2D cell cultures and animal models have limitations in replicating complex cellular interactions and human biology, organoids bridge this gap by recapitulating organ functions in 3D multicellular aggregates. These organoids, derived from stem cells or primary tissues, hold promise in studying organogenesis, drug discovery, and various diseases.
Challenges in organoid culture include maturation issues, limited functionality, and time-consuming preparation methods using materials like Matrigel. To enhance maturation, biomechanical stimuli and tissue-specific decellularized extracellular matrix (dECM) are being explored as alternatives to animal-derived ECM. The integration of multiple tissues in organoid-on-a-chip systems can further enhance organoid maturation and functionality. Current preparation methods for organoid-on-a-chip, primarily soft lithography, are time-consuming and not conducive to large-scale production. The adoption of 3D printing and injection molding offers efficient, cost-effective solutions for mass production of microfluidic chips with complex structures.
Vascularization of organoid-on-a-chip systems is essential for nutrient supply, disease modeling, and drug response studies. Co-culturing endothelial cells and organ-specific cells or inducing vascularization from pluripotent stem cells are strategies being explored to establish vascular networks in organoids. Successful vascularization enables the replication of organ functions like the blood-brain barrier and renal filtration. Future directions in organoid-on-a-chip technology include improving organoid heterogeneity, integrating vascular networks, immune cells, and multi-organ systems, and advancing design flexibility and fabrication techniques for complex organ-on-a-chip structures.
Key Takeaways:
1. Organoid-on-a-chip technology combines the advantages of organoids and microfluidics for precise control over biochemical factors, enhancing their relevance for clinical applications.
2. Challenges in organoid culture include maturation issues, limited functionality, and time-consuming preparation methods, driving research into alternatives like dECM and advanced fabrication techniques.
3. Vascularization of organoid-on-a-chip systems is crucial for nutrient supply, disease modeling, and drug response studies, with strategies focusing on co-culturing endothelial cells and inducing vascularization from pluripotent stem cells.
4. Future directions in organoid-on-a-chip technology include improving organoid heterogeneity, integrating vascular networks and immune cells, and advancing design flexibility and fabrication techniques for complex organ-on-a-chip structures.
Tags: secretion, drug delivery, tissue engineering, cell culture, automation, regenerative medicine, immunotherapy, clinical trials, bioreactor, filtration
Read more on pmc.ncbi.nlm.nih.gov
